Methods for Enhancing the Efficacy of Vascular Disrupting Agents

摘要

This invention relates to methods for treating, preventing and/or managing cancer in a subject including enhancing the efficacy of a Vascular Disrupting Agent (e.g., a combretastatin or derivative thereof) by administering to the subject an α4&bgr;1 integrin antagonist sequentially or simultaneously in combination with said Vascular Disrupting Agent.